Drawing lithography technology has recently become a popular technique to fabricate (3D) microneedles. The conventional drawing process shows some limitations in fabricating dense, scale-up and small microneedles. In this study, we demonstrate a new drawing lithography process from a self-loading mold which is able to overcome these challenges. Different from the conventional molds which have difficult alignment and loading issues, a released SU-8 membrane is attached onto a SU-8 coated wafer to generate an innovative self-loading mold. The physically distinct SU-8 colloid in this mold successfully avoids the merging of the microneedle tips in the drawing process. Meanwhile, the same SU-8 colloid in mold can provide microneedles with uniform lengths on a large surface area. Furthermore, a low temperature drawing process with this improved technique prevents sharp tips from bending during the solidification stage. Remarkably, this new drawing lithography technology can fabricate microneedles with various lengths and they are strong enough to penetrate the outermost skin layer, namely the stratum corneum. The spacing between two adjacent microneedles is optimized to maximize the penetration rate through the skin. Histology images and drug diffusion testing demonstrate that microchannels are successfully created and the drugs can permeate the tissue under the skin. The fabricated microneedles are demonstrated to deliver insulin in vivo and lower blood glucose levels, suggesting future possible applications for minimally invasive transdermal delivery of macromolecules.
Introduction
Currently, drug delivery systems are focusing on how to transport proteins, DNA, genes, antibodies and vaccines efficiently and safely into the human body. However, conventional drug delivery approaches, such as oral administration and hypodermic injection, have their limitations. For example, oral delivery may inactivate a drug through phase I metabolism [1] while hypodermic injection requires trained personnel [2] . To overcome these drawbacks, transdermal drug delivery has been attracting tremendous attention as a safe, easily accessible and patient-friendly approach [3] [4] [5] . Most biomolecules, however, cannot pass through the skin barrier due to their unfavorable hydrophilicity and macro size (over 500 Da) [6, 7] . Thus, microneedles have been introduced to create microchannels on the skin surface by penetrating the outermost layer, i.e. the stratum corneum. These so-formed transitory pores allow local permeation of drugs into the skin [8] [9] [10] [11] .
In recent years, micro-electromechanical systems (MEMS) technology has enabled microneedles to be fabricated by different materials, including silicon [12] , stainless steel [13] , titanium [14] , tantalum [15] and nickel [16] . Although these materials can be easily used to fabricate sharp microneedles and provide sufficient mechanical stiffness for penetration purposes, devices made of these materials are prone to damage [17] and may not be biocompatible [18] . As a result, polymer-based microneedles, such as SU-8 [19, 20] , polymethylmeth-acrylate (PMMA) [21, 22] , polycarbonates (PC) [23, 24] , maltose [25, 26] and polylactic acid (PLA) [27, 28] , have attracted more and more attention lately. In particular, SU-8 has been investigated intensively in recent years to fabricate microneedles due to its biocompatibility, which can be achieved after certain pretreatments (hard baking, isopropanol treatment, oxygen plasma treatments) [29] [30] [31] and its simplicity to be patterned as a structural material. Even though conventional fabrication technologies for microneedles, such as stainless steel molding technology [32] , inclined Ultraviolet (UV) exposure technology [33] , polydimethylsiloxane (PDMS) molding technology [34, 35] , reactive ion etching technology [36] and etched lens backside exposure technology [37] can be adopted to obtain devices with ultra-sharp geometry from polymer materials, they are time-consuming and expensive. To avoid these limitations, Lee et al reported a drawing lithography technology, which leveraged on the different viscosity of polymers under different temperatures, to easily pattern 3D polymer microneedles [38] [39] [40] [41] . Nevertheless, it was demonstrated that the spacing between two nearby microneedles was critical for the successful formation of individual microneedles [42, 43] : a distance between two neighboring microneedles smaller than 900 µm was shown to be detrimental for the formation of individual needles. It was also found that, when the density of the microneedles kept increasing, parts of the microneedles formed clusters rather than sharp tips ( figure 1(a) ). This represented the main hurdle for this drawing lithography technology and hampered the fabrication of dense microneedles. Moreover, from the mathematical model reported previously [44] , the length of the microneedles was mainly determined by the extensional strain rate in the polymers. In the conventional drawing lithography process, the length of microneedles was controlled by adjusting the temperature, which affected the extensional strain rate. However, the temperature distribution and the rate of change in the temperature were not necessarily uniform over the baked polymers. Hence, the lengths of fabricated microneedles may vary remarkably across the same sample, especially when this sample has a large area. Thus, the temperature control mechanism had a constraint for the scale-up of the microneedles in drawing lithography technology. Furthermore, the previous process needed a relatively high temperature for low polymer viscosity to obtain smaller microneedles. However, there was a high chance that this high temperature led microneedle tips to bend in the final solidification process ( figure 1 (b) ), which impeded the successful fabrication of small microneedles by drawing lithography technology.
Taking all of these limitations into consideration, we demonstrated a new drawing lithography process from a selfloading mold, which is able to overcome these challenges. A released SU-8 membrane was attached onto a SU-8 coated wafer to generate an innovative self-loading mold. Physically separated SU-8 colloid in this mold successfully avoids any merging of the microneedle tips in the drawing process. Meanwhile, the same SU-8 colloid in the mold can provide microneedles with uniform lengths on a large surface area. The low temperature drawing process in this improved technique prevents sharp tips from bending during the solidification stage. Remarkably, this new drawing lithography technology can fabricate microneedles with various lengths and which are strong enough to penetrate the stratum corneum. In vitro and in vivo tests prove the successful penetration of fabricated microneedles and its feasibility to deliver macromolecules such as insulin.
Design and fabrication
The fabrication process is shown in figure 2 . It can be divided into three parts: self-loading SU-8 mold fabrication, SU-8 pillar fabrication and SU-8 tip fabrication.
A self-loading SU-8 mold, from which the microneedles were drawn, was designed to physically separate SU-8 source and control the source volume. In conventionally patterned mold, the source material needs to be loaded inside the mold [45] . It requires a fine alignment and the loading volume is hard to control precisely. Therefore, we applied a released SU-8 membrane on top of a wafer coated with SU-8 to implement a self-loading SU-8 mold.
The fabrication of the self-loading SU-8 mold started from a layer of polyethylene terephthalate (PET, 3M USA) film pasted onto a Si substrate by sticking the edge area with kapton tape (figure 2 (1a)). After spin coating, soft baking, UV exposure and development, a 350 µm thick SU-8 membrane was patterned on the PET substrate ( figure 2 (1b) ). Due to poor adhesion between the PET film and the cross-linked SU-8 layer, the SU-8 membrane could be easily released from the PET substrate by removing the kapton tape and slightly bending the PET film (figure 2 (1c)). A layer of 250 µm thick SU-8 was spin coated onto another piece of wafer. This wafer was soft baked to minimize the SU-8 fluidity. The SU-8 membrane was then attached onto the baked SU-8 wafer (figure 2 (1e)). By applying a slight depression with tweezers, the SU-8 membrane was stuck onto the substrate and the SU-8 colloid filled in the holes ( figure 2(1f) ). Since the highly viscous SU-8 2100 was chosen as the source, the SU-8 colloid could be controlled precisely to fill into the holes on the membrane without any spillage. In this way, a self-loading SU-8 mold filled with SU-8 source was prepared without any tedious loading process.
An array of 350 µm high SU-8 pillars was fabricated on a glass substrate as a frame to draw the SU-8 colloid. A uniform spin coating is critical to the patterning of SU-8 pillars with the same height. In order to avoid the common edge effect in the thick photoresist patterning process [46] , the SU-8 deposition was conducted in two steps. In each step, SU-8 2100 was spun at 2000 rpm for 30 s, followed by prebaking steps at 65 °C for 10 min and 95 °C for 120 min. After the prebaking steps, this SU-8 layer was exposed to 650 mJ cm −2 ultraviolet energy and developed to define the structure of the pillars (figure 2 (2b)).
The fabrication of the SU-8 tips was divided into four steps. First, the SU-8 pillar sample was flipped over and attached to a precision stage, which could control the sample position in three-dimension. The self-loading SU-8 mold was fixed on a 95 ºC hotplate surface ( figure 2 (3a) ). Secondly, since the SU-8 pillars were fabricated on a transparent glass substrate, it was easy to align the pillars with the self-loading SU-8 mold by backside observation. The device of the SU-8 pillars was immersed in the mold and the SU-8 colloid was coated on the surface of the pillars ( figure 2 (3b) ). Thirdly, the SU-8 pillars were drawn away from the SU-8 colloid. Since the temperature in the air was lower than the temperature in the SU-8 colloid, the coated SU-8 quickly solidified. Due to the limited SU-8 source in the self-loading mold, the connection between the SU-8 pillars and the SU-8 colloid gradually became a SU-8 bridge during the drawing process ( figure 2 (3c) ). At last, when the drawing speed was increased, the connection shrank and then broke. The end of the shrunken SU-8 bridges formed sharp conical tips at the top of the SU-8 pillars ( figure  2 (3d) ). The SU-8 microneedle device was then UV exposed, post baked, hard baked and treated with oxygen plasma. This postprocessing step not only induced a crosslink in the SU-8 to enhance the stiffness of the device, but also increased its biocompatibility [30] . Different from the drawing lithography technology that we reported before [43, 47] , the baking temperature in this drawing process was not changed. Therefore, it avoided any bending of the tips, which is normally induced by high temperature.
In the whole process, all the SU-8 colloid was confined in a self-loading mold and physically separated from each other. It prevented the SU-8 microneedles from merging even when the nearby micropillars were close to each other. Meanwhile, the same SU-8 source volume controlled by the patterned SU-8 membrane led to uniform lengths for the fabricated microneedles. Finally, the low-temperature process in the SU-8 mold avoided the formation of bent tips at the end of the microneedles.
Results and discussion

Length dependency of microneedles
In conventional processes, the length of microneedles is controlled by the baking temperature. Polymer viscosity decreases as the baking temperature increases, which leads to a lower extensional strain rate in the polymer. To a certain extent, polymer gravity force dominates extension force and the drawn polymer end shrinks into sharp tips [47] . However, we noticed that when the size of the microneedles is reduced, the increased temperature resulted in bent tips. Therefore, the SU-8 mold that we used in this new drawing process was aimed at solving this problem. Since the height of the mold was the same as the thickness of the SU-8 membrane, the volume of the mold was only determined by the diameter of the holes on the membrane. Thus, the SU-8 colloid source inside the mold could be controlled by changing the diameter of the holes. If the volume of the SU-8 colloid source was limited, when most of the SU-8 colloid was drawn away by the SU-8 pillars and solidified, the SU-8 colloid left in the mold would not be sufficient to form a cylindrical shape. Indeed, since the SU-8 colloid in the mold became less and less, the drawn SU-8 microneedles gradually formed a conical shape and ended with a sharp tip. Figure 3 shows the microneedles with different lengths fabricated by changing the diameter of the holes rather than by increasing the temperature. In order to study the relationship between the diameter of the holes on the membrane and the corresponding length of the drawn microneedles, membranes with different holes were used as molds to fabricate the microneedles. The varying diameters ranged from 240 to 510 µm with 30 µm intervals. Ten samples were fabricated to calculate the errors in each diameter. The results are shown in figure 4 . From the measurement, it was confirmed that the microneedles fabricated according to this method are uniform and repeatable. Their lengths can be controlled by the diameter of the holes on the membrane.
Stiffness testing for microneedles
The microneedles were mainly used to create microchannels on the skin surface. In order to prove that the microneedles had sufficient stiffness for successful penetration, their buckling force was tested. Microneedles with varying lengths from 400 to 1000 µm were loaded under an axial compression with Instron Microtester 5848 (Instron, USA). Ten microneedles with the same length were tested in each group. The equipment drove a microneedle against a metal plate at a speed of 20 µm s −1 until the microneedle broke. Davis et al [48] had studied the failure point of microneedles and defined that the sharp discontinuity point marked the fracture of the microneedle, which was also adopted by Mansoor et al [16] and Geyssens et al [49] . We followed the same method in the measurement of our microneedles. The failure loading point could be observed when the loading sensor output had a sharp change. The force and its corresponding displacement data were recorded by a computer. Figure 5 (a) demonstrates one representative example of buckling force testing for a 500 µm high microneedle. The axial force applied to the microneedle increased with the plate displacement until the maximum load was reached. The fracture threshold was indicated by a discontinuity in the detected force and confirmed by visual observation during the test. After this fracture point, the loading plate continued to press against the crushed microneedle under less force. Figure 5(b) showed the microneedles' buckling force changed with their lengths. From Euler's equation,
2 the buckling force is proportional to the area moment of inertia, I. The cross section of the microneedle is approximately a circle. Thus, its area moment of inertia has an exponential growth with the microneedle radius. For our devices, the length and cross section area of the microneedles were determined by the SU-8 source in the mold. Those microneedles whose lengths were less than 500 µm did not have sufficient SU-8 source to form a perfect conical geometry (figures 3(a) and (b)). The base area of these microneedles shrunk sharply, resulting in a relatively small bucking force in this range. Longer microneedles took more SU-8 source from the cavities in the mold, which resulted in a decreased curvature in their bottom part and a larger cross section area. Thus, the corresponding buckling force increased. However, when the microneedles' length was larger than 800 µm, their base area was similar to the fixed cross section area of micropillars, which were used as frames in the drawing lithography process. Their corresponding buckling force therefore tended to be constant.
Optimization of microneedle spacing
In theory, denser microneedles would contribute to the formation of more microchannels on the skin surface, which would enhance the transdermal delivery of bioactive molecules. However, as addressed in the introduction, the previous drawing lithography technology was confronted with a density limitation: when the spacing between two nearby microneedles was reduced to less than 900 µm, their tips merged into clusters rather than forming individual microneedles [43] .
Therefore, in this study, a self-loading SU-8 mold was leveraged to solve this problem. As described in the fabrication process, the SU-8 mold was a SU-8 membrane attached onto the SU-8 colloid surface ( figure 6(b) ). The SU-8 colloid source was physically separated by the SU-8 mold and their spacing was determined by the distance D on the membrane ( figure 6(a) ). Since the nearby SU-8 colloid source had no overlap between each other, the spacing of the microneedles could shrink to a narrow gap. However, Yan et al reported that a 'nail bed' effect may occur when the density of the microneedles is increased [50] . When an excess number of microneedles was applied to a small skin sample, the force distributed among the microneedles was not sufficient for a single microneedle to penetrate the skin surface. Therefore, although the self-loading SU-8 mold could offer an approach to fabricate a denser microneedle chip, its density needed to be optimized to guarantee skin penetration efficiency. A batch of 10 × 10 microneedle arrays which had the same length but different spacing was fabricated to study the optimized spacing. Their spacing changed from 200 to 500 µm with 50 µm intervals. After these microneedles were applied to a rats' skin surface with the same force, 50 µL of methylene blue was used to stain the skin samples. The stain was left on the sample for 10 min and then the excess stain was removed by ethanol wipes. Since the methylene blue only diffused into the penetrated holes, the penetration rate was visually evaluated through the recorded images. Figure 7 shows the representative results. When the spacing increased, it was obvious that more microneedles successfully penetrated the skin surface. From the 70 testing samples (10 samples for each spacing), we summarized their penetration rate ( figure 8) . If the spacing between two nearby microneedles was larger than 400 µm, more than 95% of the microneedles could successfully create microchannels on the skin samples. Most microneedles on the samples with smaller spacing, however, failed to penetrate the skin. Therefore, 400 µm spacing was chosen as the optimal value to fabricate our final devices.
Histological examination
Histological images were taken to show the details of the microchannels created by the fabricated microneedles. Skin samples after penetration were washed in 1X phosphate buffered saline (PBS) (Vivantis Inc US) and fixed in 4% paraformaldehyde (Electron Microscopy Sciences, USA) for 48 h at 4 °C. Then cryoprotection with 30% Sucrose (Fischer Scientific, UK) was applied to the samples for 24 h at 4 °C and embedded with an optimal cutting temperature (OCT) medium. Cryosections of 20 µm were sliced and dried at room temperature for 24 h, stained with hematoxylin and eosin (H and E) to locate the microneedle penetration in the skin. The result is shown in figure 9 . The penetration successfully induced conical microchannels on the skin epidermis for delivery purposes.
Drug diffusion testing in vitro
The data presented so far have shown microneedle penetration, but not addressed the drug diffusion process. After the rat skin was pretreated with the fabricated microneedles, the device induced microchannels on the skin surface. The drug diffused to the tissue through these microchannels. In order to present this scenario, 200 µL of physiological saline solution containing fluorescent Sulforhodamine (SigmaAldrich, Singapore) was applied to the rat skin sample after it was pretreated with the fabricated microneedles. Then the skin sample was investigated by a confocal microscope. The permeation pattern of the florescent solution along the microchannels showed the solution diffusion results. Figure 10 indicates the diffused area from a depth of 20 to 180 µm below the skin surface. The black area was a control area without any diffused florescence. In contrast, the illuminated tissues indicated the area where the solution diffused through. Since the microchannels were created by the conical microneedles, the diameter of the microchannel decreased when the penetrated depth increased. Most of the Sulforhodamine solution was confined to the microchannels and only some of it diffused to the nearby tissue. Thus, the diffusion area also decreased in the deeper region.
Transdermal delivery of insulin in vivo
Transdermal delivery of insulin was tested in vivo to prove the function of fabricated microneedles in practical experiments. All the procedures were performed under protocol and approved by the Institutional Animal Care and Use Committee at the National University of Singapore.
200 ~ 250 g Sprague-Dawley rats were injected with 50 mg kg −1 streptozotocine (Sigma-Aldrich, Singapore) in citrate buffer (pH 4.2) by intraperitoneal injection to generate a diabetic animal model. These rats were kept with free access to food and water for 3 days. Then their blood glucose level was checked by a glucometer (Accu-Chek, USA). The successful induction of diabetes was verified if the blood glucose level was at least 16.7 mM (300 mg dl −1 ). The rats with blood glucose level between 20 and 30 mM were selected and the hairs on the abdomen skin were removed 24 hours before the experiment. All these rats were divided into 3 groups and each group contained 3 rats. Group 1 was a negative control group, in which we conducted passive diffusion experiments. After the rats were anesthetized, 0.5 mL 100 IU mL −1 Lispro insulin (Sigma-Aldrich, Singapore) in phosphate buffered saline (pH 7.4) was slowly added on the abdomen skin. A piece of parafilm was fixed on top of the skin with scotch tape to avoid solution leakage and evaporation. Group 2 was an experimental group. After the rats were anesthetized, the fabricated microneedle sample, which had been disinfected with 75% ethanol, was applied on the abdomen skin surface. Then the same insulin solution as in group 1 was slowly added on the abdomen skin and the skin was covered by the parafilm to avoid any leakage and evaporation. In group 3, after the rats were anesthetized, 10 IU mL −1 Lispro insulin was injected subcutaneously with a 29 G hypodermic needle into the rats (2.5 IU kg −1 ) as a positive control experiment. Blood samples were taken from the tail vein every 30 minutes after the beginning of the experiments in all groups. The blood glucose level monitoring lasted for 6 hours. A glucometer (Accu-Chek, USA) was used to give the corresponding blood glucose levels. The results are shown in figure 11 . The blood glucose level in rats treated by fabricated microneedles dropped continuously during the 6 hours insulin delivery period and was eventually stable. It was significantly different compared with the negative control group, where insulin solution was applied on the non-pretreated skin surface. Remarkably, the changing of the blood glucose level in the positive control experiments, in which the rats were injected with insulin by hypodermic needle, was similar to the change in the experimental group 2, in which the rats were treated with microneedles. This experiment successfully proved the ability of fabricated microneedles to deliver macromolecules like insulin and their performance was comparable to the conventional hypodermic injection.
Conclusion
In this study, we reported a new drawing lithography process for dense, scale-up and small microneedles fabrication. A released SU-8 membrane is attached onto a SU-8 coated wafer to make up the innovative self-loading mold. This new approach can solve the usual problems, such as merged microneedles, nonuniform microneedle length and bent tips, in the conventional fabrication process. The spacing between two adjacent microneedles is optimized to maximum penetration rate on the skin surface. Moreover, histology images and drug diffusion testing demonstrate that microchannels are successfully created and drugs can permeate the tissue under the skin. The fabricated microneedles are demonstrated to deliver insulin in vivo and lower blood glucose levels, which suggest future possible usage for minimally invasive transdermal delivery of macromolecules. Changes in blood glucose level in diabetic rats after insulin delivery using microneedles (•), subcutaneous hypodermic injection of insulin (■) and passive delivery across untreated skin (▲).
